SPL
NVCR icon

Superior Planning, LLC’s NovoCure NVCR Stock Holding History

Superior Planning, LLC’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15K Buy
+72
New +$1.2K ﹤0.01% 1721

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Superior Planning, LLC's NVCR Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in NovoCure (NVCR) in Q3 2026: 72 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #1721 among its holdings.

149 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Superior Planning, LLC held 72 shares of NovoCure worth $1.15K as of Q3 2026.
  • NovoCure was a new Superior Planning, LLC position in Q3 2026.
  • NovoCure made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1721 holding.
  • 149 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.